About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
PediCAP surpasses 25% patient recruitment milestone
Risk-proportionate approach to paediatric clinical trials: The legal requirements, challenges, and the way forward under the European Union Clinical Trials Regulation
Penta ID Network Meeting (PIM) 2022
HIV HGM biobank as a research platform for paediatric infectious diseases and COVID-19 pandemic
Youth engagement and participation in clinical trials
Penta at the Global Child Health Mini-Symposium in Oxford April 7th 2022
Penta investigates cases of acute hepatitis of unknown origin in children
RBDCOV initiates the first Phase III clinical trial of HIPRA’s Covid-19 vaccine in immunocompromised people
Capacitating the future of research in paediatric HIV
Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years
The EPIICAL story